Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3360
-0.0030 (-0.88%)
Jun 16, 2026, 10:28 AM CET

Enorama Pharma AB Statistics

Total Valuation

STO:ERMA has a market cap or net worth of SEK 25.29 million. The enterprise value is 7.52 million.

Market Cap25.29M
Enterprise Value 7.52M

Important Dates

The next estimated earnings date is Friday, August 21, 2026.

Earnings Date Aug 21, 2026
Ex-Dividend Date n/a

Share Statistics

STO:ERMA has 74.59 million shares outstanding. The number of shares has increased by 26.99% in one year.

Current Share Class 74.59M
Shares Outstanding 74.59M
Shares Change (YoY) +26.99%
Shares Change (QoQ) n/a
Owned by Insiders (%) 20.38%
Owned by Institutions (%) 1.69%
Float 15.81M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 11.59
PB Ratio -0.69
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 3.45
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio 0.64
Quick Ratio 0.55
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -124.14%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 466.79%
Weighted Average Cost of Capital (WACC) 13.54%
Revenue Per Employee 545,500
Profits Per Employee -16.32M
Employee Count4
Asset Turnover 0.07
Inventory Turnover 2.16

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -85.00% in the last 52 weeks. The beta is 1.69, so STO:ERMA's price volatility has been higher than the market average.

Beta (5Y) 1.69
52-Week Price Change -85.00%
50-Day Moving Average 0.34
200-Day Moving Average 1.59
Relative Strength Index (RSI) 47.11
Average Volume (20 Days) 49,722

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, STO:ERMA had revenue of SEK 2.18 million and -65.27 million in losses. Loss per share was -0.90.

Revenue2.18M
Gross Profit -7.31M
Operating Income -57.99M
Pretax Income -65.27M
Net Income -65.27M
EBITDA -57.91M
EBIT -57.99M
Loss Per Share -0.90
Full Income Statement

Balance Sheet

The company has 17.76 million in cash and n/a in debt, with a net cash position of 17.76 million or 0.24 per share.

Cash & Cash Equivalents 17.76M
Total Debt n/a
Net Cash 17.76M
Net Cash Per Share 0.24
Equity (Book Value) -36.64M
Book Value Per Share -0.49
Working Capital -12.60M
Full Balance Sheet

Cash Flow

Operating Cash Flow -45.27M
Capital Expenditures n/a
Depreciation & Amortization 77,000
Net Borrowing 36.18M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -2,657.61%
Pretax Margin -2,991.43%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

STO:ERMA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -26.99%
Shareholder Yield -26.99%
Earnings Yield -258.14%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

STO:ERMA has an Altman Z-Score of -26.82 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -26.82
Piotroski F-Score 1